Baker Bros. Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $598M | Buy |
|
|||||
|
2025
Q1 | $654M | Hold |
|
|||||
|
2024
Q4 | $609M | Hold |
|
|||||
|
2024
Q3 | $419M | Hold |
|
|||||
|
2024
Q2 | $553M | Buy |
|
|||||
|
2024
Q1 | $526M | Hold |
|
|||||
|
2023
Q4 | $456M | Buy |
|
|||||
|
2023
Q3 | $226M | Hold |
|
|||||
|
2023
Q2 | $357M | Hold |
|
|||||
|
2023
Q1 | $374M | Hold |
|
|||||
|
2022
Q4 | $448M | Buy |
|
|||||
|
2022
Q3 | $97.4M | Hold |
|
|||||
|
2022
Q2 | $107M | Hold |
|
|||||
|
2022
Q1 | $147M | Hold |
|
|||||
|
2021
Q4 | $127M | Hold |
|
|||||
|
2021
Q3 | $120M | Hold |
|
|||||
|
2021
Q2 | $146M | Hold |
|
|||||
|
2021
Q1 | $175M | Hold |
|
|||||
|
2020
Q4 | $167M | Hold |
|
|||||
|
2020
Q3 | $178M | Buy |
|
|||||
|
2020
Q2 | $170M | Hold |
|
|||||
|
2020
Q1 | $100M | Buy |
|
|||||
|
2019
Q4 | $107M | Hold |
|
|||||
|
2019
Q3 | $101M | Hold |
|
|||||
|
2019
Q2 | $123M | Hold |
|
|||||
|
2019
Q1 | $146M | Hold |
|
|||||
|
2018
Q4 | $132M | Hold |
|
|||||
|
2018
Q3 | $250M | Hold |
|
|||||
|
2018
Q2 | $327M | Buy |
|
|||||
|
2018
Q1 | $71.9M | Hold |
|
|||||
|
2017
Q4 | $56.5M | Buy |
|
|||||
|
2017
Q3 | $2.6M | Hold |
|
|||||
|
2017
Q2 | $939K | Hold |
|
|||||
|
2017
Q1 | $890K | Hold |
|
|||||
|
2016
Q4 | $861K | Hold |
|
|||||
|
2016
Q3 | $732K | Sell |
|
|||||
|
2016
Q2 | $526K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $949K | Sell |
|
|||||
|
2014
Q4 | $1.32M | Hold |
|
|||||
|
2014
Q3 | $1.5M | Hold |
|
|||||
|
2014
Q2 | $2.04M | Hold |
|
|||||
|
2014
Q1 | $2.15M | Hold |
|
|||||
|
2013
Q4 | $2.62M | Hold |
|
|||||
|
2013
Q3 | $3.15M | Sell |
|
|||||
|
2013
Q2 | $6.98M | Buy |
|